<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02656121</url>
  </required_header>
  <id_info>
    <org_study_id>PCO</org_study_id>
    <nct_id>NCT02656121</nct_id>
  </id_info>
  <brief_title>Correction of Vitamin D Deficiency and Its Effect on Ovulation Induction in Women With PCOS (VIDEO): A Feasibility RCT</brief_title>
  <acronym>PCOSD</acronym>
  <official_title>Correction of Vitamin D Deficiency and Its Effect on Ovulation Induction in Women With PCOS (VIDEO): A Feasibility RCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, a special emphasis has recently been directed to the potential role of vitamin D
      and some regulatory peptides (e.g. adipokines and follistatin) and their associated metabolic
      roles and genetic factors in the development of PCOS and its related co-morbidities. The aim
      of this study was to assess the feasibility of conducting a pragmatic RCT assessing the
      effectiveness of adopting a protocol of screening for and correcting Vitamin D deficiency in
      women with PCOS seeking fertility treatment in a low/middle income care (LMIC) setting
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research question:

      In PCOS patients, is there any effect of vitamin D testing and correction on ovulation
      induction in women with PCOS?

      Research hypothesis:

      There is effect of testing and correcting vitamin D status as regard ovulation in patients
      with PCOS
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">November 2018</completion_date>
  <primary_completion_date type="Actual">November 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cumulative clomiphene citrate-induced ovulation rates</measure>
    <time_frame>6 months</time_frame>
    <description>Ultrasound Folliculometry was performed every other day starting on the 10th day of the induction cycle. Until, at least, one follicle reached 18mm in diameter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumlative clinical pregnancy rate</measure>
    <time_frame>6 months</time_frame>
    <description>detection of fetal heart activity detected by transvaginal ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>median ovulating dose of clomiphene citrate</measure>
    <time_frame>6 months</time_frame>
    <description>Dose required</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1st subgroup will be tested and treated with vitamin D together with Clomiphene Citrate for induction of ovulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2nd subgroup will be treated with Clomophene Citrate only</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>6000 IU of vitamin D3</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>VidropÂ®, Medical Union Pharmaceuticals, Egypt</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ovulatory Agent</intervention_name>
    <description>only Clomophine Citrate</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_label>control</arm_group_label>
    <other_name>Clomiphene Citrate for induction of ovulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed PCOS cases according to the National Institute of Health criteria (NIH
             consensus criteria) and Rotterdam criteria

        Exclusion Criteria:

          -  1- PCOS patients not in child bearing age; less than 18 years or more than 45 years.

             2- Patients with congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's
             syndrome, hyperprolactinemia and virilizing ovarian or adrenal tumors.

             3- PCOS patients with any other medical illness. 4- PCOS patients already on vitamin D
             supplements.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M kotb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <state>Al Qahirah</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>January 12, 2016</study_first_submitted>
  <study_first_submitted_qc>January 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2016</study_first_posted>
  <last_update_submitted>November 15, 2018</last_update_submitted>
  <last_update_submitted_qc>November 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed El Kotb Abdel Fattah</investigator_full_name>
    <investigator_title>Dr. Ahmed Kotb</investigator_title>
  </responsible_party>
  <keyword>PCOS, vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

